SIRT6 and persistent truncus arteriosus: We showed that SIRT6 overexpression increased survival, attenuated TAC-induced heart damage and dysfunction, decreased myocardial inflammation induced by TAC, and reduced the areas of fibrosis and infarct size in TAC mice.